Treatment (3) Docosahexaenoic acid (3) Dopa (3) Parkinson's disease (3) Movement disorders (3) Monkeys (3) Basal ganglia (3) spectacle (2) primates (2) acide (2) effet (2) maladie (2) Scores (2) Naltrexone (2) Kynurenine (2) Tallies (2) Messenger RNA (2) Drugs (2) Dopamine (2) Denervation (2) Caudate nucleus (2) Brain (2) cerveau (2) maladie (2) administration (1) temps (durée) (1) thérapie (1) risque (1) région (1) modèle (1)